Stock Rich List
#11514 on the rich list of 14,644 insiders

John C. Reed

EVP, Innovative Medicine, R&D at Johnson & Johnson; Director at Madrigal Pharmaceuticals. Based in West Conshohocken, Pennsylvania.

$6.9M
in disclosed stock, −$142K (−2.02%) today
Market closed. Prices as of Nov 19, 4:00 PM ET
Rank
11514th of 14,644
Companies held
2
Largest holding
JNJ, 96.3% of total
Latest SEC filing
Aug 15, 2026

What the $6.9M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Johnson & Johnson JNJ
Common Stock
Directly24,911$267.02$6.7M96.3%Form 4, May 1, 2026
Madrigal Pharmaceuticals MDGL
Common Stock
Directly647$396.74$257K3.7%Form 4, Aug 15, 2026

Share counts are the amounts John C. Reed reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Feb 17, 2026SoldJNJ29,927$243.00$7.3MView
Feb 17, 2026SoldJNJ2,283$243.00$555KView
Feb 17, 2026SoldJNJ21,721$243.00$5.3MView
Oct 17, 2025SoldJNJ21,721$192.71$4.2MView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
11511Christopher Wade
Chief Technology Officer, Cellebrite DI
$6.9M+$98K (+1.43%)
11512Robert S. Genter
Sector President, Science Applications International. Reston, VA
$6.9M−$179K (−2.52%)
11513Mary A. Winston
Director, Dover. Newport Beach, CA
$6.9M−$98K (−1.40%)
11514John C. Reed
EVP, Innovative Medicine, R&D, Johnson & Johnson. West Conshohocken, PA
$6.9M−$142K (−2.02%)
11515Brian Poff
EVP, Chief Financial Officer, Addus HomeCare. Frisco, TX
$6.9M+$13K (+0.18%)
11516Matthew J. Kurtenbach
VP of Manufacturing, Daktronics. Brookings, SD
$6.9M−$176K (−2.49%)
11517John F. Walsh
CEO-Americas, Accenture. Chicago, IL
$6.9M−$278K (−3.86%)

Other Johnson & Johnson insiders

All JNJ insiders

Questions

How much stock does John C. Reed own?

John C. Reed holds $6,908,426 in listed stock based on SEC filings and current prices, mostly Johnson & Johnson (JNJ). That ranks 11514th on the Stock Rich List.

Is this John C. Reed's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did John C. Reed last buy or sell stock?

The most recent open-market trade on file is a sale of 29,927 JNJ shares on Feb 17, 2026 at $243.00.